(S)-Rabeprazole(177795-59-4)
- Name: (S)-Rabeprazole
- Synonyms:2-[(S)-[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole;
- Molecular Formula:C18H21N3O3S
- Molecular Weight:359.44300
- CAS Registry Number:177795-59-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.177795-59-4 (S)-Rabeprazole
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.177795-59-4 (S)-Rabeprazole
Assay:97% Appearance:powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 177791-33-2/1H-Pyrido[3,4-b]indole, 1-[(3,4-dimethoxyphenyl)methyl]-2,3,4,9-tetrahydro-6-(methylthio)-, monohydrochloride
- 177791-34-3/1H-Pyrido[3,4-b]indole-6-carboxylic acid, 2,3,4,9-tetrahydro-1-(1-naphthalenylmethyl)-, monohydrochloride
- 177791-36-5/1H-Pyrido[3,4-b]indole, 6-ethyl-2,3,4,9-tetrahydro-1-(1-naphthalenylmethyl)-, (Z)-2-butenedioate (1:1)
- 177791-38-7/1H-Pyrido[3,4-b]indole, 1-[(3,4-dimethoxyphenyl)methyl]-2,3,4,9-tetrahydro-6-propyl-, (Z)-2-butenedioate (1:1)
- 177791-40-1/1H-Pyrido[3,4-b]indole, 6-butyl-1-[(3,4-dimethoxyphenyl)methyl]-2,3,4,9-tetrahydro-, (Z)-2-butenedioate (1:1)
- 177791-41-2/1H-Pyrido[3,4-b]indole, 1-[(3,4-dimethoxyphenyl)methyl]-2,3,4,9-tetrahydro-6-phenyl-, monohydrochloride
- 177791-44-5/1H-Pyrido[3,4-b]indole, 1-[(2-bromo-3,4-dimethoxyphenyl)methyl]-2,3,4,9-tetrahydro-6-methyl-, monohydrochloride
- 177791-45-6/1H-Pyrido[3,4-b]indole, 1-[(3,4-dimethoxy-2-nitrophenyl)methyl]-2,3,4,9-tetrahydro-6-methyl-, monohydrochloride
- 177791-46-7/Benzenamine, 2,3-dimethoxy-6-[(2,3,4,9-tetrahydro-6-methyl-1H-pyrido[3,4-b]indol-1-yl )methyl]-, dihydrochloride
- 177791-48-9/1H-Pyrido[3,4-b]indole, 1-[(3,5-difluorophenyl)methyl]-2,3,4,9-tetrahydro-6-methyl-, (Z)-2-butenedioate (1:1)
- 177791-50-3/1H-Pyrido[3,4-b]indole, 1-[(3,4-difluorophenyl)methyl]-2,3,4,9-tetrahydro-6-methyl-, (Z)-2-butenedioate (1:1)
- 177791-51-4/1H-Pyrido[3,4-b]indole, 2,3,4,9-tetrahydro-6-methyl-1-[[3-(trifluoromethyl)phenyl]methyl]-, monohydrochloride
- 177791-53-6/1H-Pyrido[3,4-b]indole, 1-[(3,4-dimethoxyphenyl)methyl]-2,3,4,9-tetrahydro-6,9-dimethyl-, monohydrochloride
- 177791-55-8/1H-Pyrido[3,4-b]indole, 1-[(3,4-dimethoxyphenyl)methyl]-2,3,4,9-tetrahydro-1,6-dimethyl-, (Z)-2-butenedioate (1:1)
- 177791-57-0/2H-1-Benzopyran-2-one, 3-(4-chlorobenzoyl)-4-hydroxy-
- 17779-19-0/2(3H)-Furanone, dihydro-5,5-dimethyl-4-(2-methyl-1-propenyl)-, (R)-
- 17779-27-0/Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, methyl ester, (1R,3S)-rel-
- 177792-88-0/Furo[2,3-b]pyridine, 5-(chloromethyl)-, hydrochloride
- 177792-89-1/L-Arginine, L-tyrosyl-L-seryl-L-phenylalanyl-L-lysyl-L-prolyl-L-methionyl-L-prolyl-L-leucyl- D-alanyl-
- 177795-59-4/(S)-Rabeprazole
- 177795-60-7/(R)-Rabeprazole
- 177799-11-0/9,10-Anthracenediamine, N,N,N',N'-tetraphenyl-
- 177799-61-0/Benzenamine, 4-[(1Z)-2-chloroethenyl]-N,N-dimethyl-
- 1778-10-5/Benzoic acid, 4-(methylthio)-, ethyl ester
- 17781-05-4/2-Amino-4-methyl-4-hexenoic acid
- 17781-11-2/2,4,6,8-Nonatetraenal, 9-(6,6-dimethyl-1-cyclohexen-1-yl)-3,7-dimethyl-, (Z,E,E,E)-
- 1778-11-6/Benzoic acid, 4-selenocyanato-, ethyl ester
- 17782-39-7/Pyrrolidine, 1-(1-phenylethyl)-
- 17782-59-1/Bicyclo[3.2.1]oct-6-ene, 3-methylene-
- 1778-26-3/Hydrazinecarbothioamide, N-propyl-2-(2-thienylmethylene)-